availability of semaglutide Day 2: Wegovy (Semaglutide 2.4 mg weekly injection) Class: GLP-1 receptor agonist Avg Weight Loss: ~15% baseline weight Dosing: Weekly subcutaneous injection FDA Approved: June 2021 for chronic weight management Pros Shortage update from https://www.accessdata.fda.gov/ website
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
























